Pfizer's Stage 3 Results On TRUMENBA Meet All Endpoints
May 13, 2016 at 08:15 AM EDT
Pfizer Inc. (NYSE: PFE) disclosed the results of two stage 3 trials demonstrating the immunogenicity of TRUMENBA (Meningococcal Group ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.